| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/21/2002 | WO2001083698A3 Compositions and methods for inducing activation of dendritic cells |
| 02/21/2002 | WO2001081608A3 Viral vectors for use in monitoring hiv drug resistance |
| 02/21/2002 | WO2001079443A3 Albumin fusion proteins |
| 02/21/2002 | WO2001077149A3 Regulation of human cyslt2-like gpcr protein |
| 02/21/2002 | WO2001068802A3 Genes of il-12p40 subunit mutated for improving the activity of il-12 and use thereof for dna vaccine adjuvant |
| 02/21/2002 | WO2001066597A3 Inflammation-related gene |
| 02/21/2002 | WO2001064240A3 Methods for promoting production of myelin by schwann cells |
| 02/21/2002 | WO2001062901A3 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 02/21/2002 | WO2001057069A3 Targeting peptides |
| 02/21/2002 | WO2001055391A3 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
| 02/21/2002 | WO2001055319A3 Endocrine related nucleic acids, proteins and antibodies |
| 02/21/2002 | WO2001047510A3 Methods and compositions related to modulators of annexin and cartilage homeostasis |
| 02/21/2002 | WO2001044282A3 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 02/21/2002 | WO2001031005A3 Drosophila g protein coupled receptors, nucleic acids, and methods related to the same |
| 02/21/2002 | WO2000066148A9 Novel proteins |
| 02/21/2002 | US20020022718 Genes identified as required for proliferation of E. coli |
| 02/21/2002 | US20020022599 Methods of modulating drug clearance mechanisms by altering SXR activity |
| 02/21/2002 | US20020022592 Delivery of thrombospondin from implantable tissue matrices |
| 02/21/2002 | US20020022270 Human tissue cultures; inoculate vessel containing stromal tissue, continuously perfuse issue with nutrient broth, harvest preferential human tissue |
| 02/21/2002 | US20020022259 Cardiac-cell specific enhancer elements and uses thereof |
| 02/21/2002 | US20020022229 Detecting genetic disorder; obtain sample, detect bone morphogenic protein mutation, the presence of mutation indicates genetic disorder |
| 02/21/2002 | US20020022029 Human RRP sequences and methods of use |
| 02/21/2002 | US20020022027 Complexing to polypeptides; antiproliferation agent |
| 02/21/2002 | US20020022026 Osteoporosis |
| 02/21/2002 | US20020022023 Treatment of diabetes mellitus and insulin receptor signal transduction |
| 02/21/2002 | US20020022021 Method of regulating transcription in a cell |
| 02/21/2002 | US20020022018 Controlling gene expression |
| 02/21/2002 | CA2419790A1 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 02/21/2002 | CA2419725A1 Genes involved in immune related responses observed with asthma |
| 02/21/2002 | CA2419418A1 Vaccines containing ribavirin and methods of use thereof |
| 02/21/2002 | CA2419245A1 Adeno-associated virus-mediated delivery of angiogenic factors |
| 02/21/2002 | CA2419020A1 Pyruvate:nadp+ oxidoreductase and uses thereof |
| 02/21/2002 | CA2417152A1 Therapeutic compounds for ovarian cancer |
| 02/21/2002 | CA2417141A1 Novel glycoproteins and methods of use thereof |
| 02/20/2002 | EP1180525A1 Transcriptional activation inhibitory protein |
| 02/20/2002 | EP1180524A1 Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides |
| 02/20/2002 | EP1180243A2 Uses of notch related genes |
| 02/20/2002 | EP1180239A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer |
| 02/20/2002 | EP1180168A1 MOLECULAR CHARACTERISATION OF CHROMOSOME TRANSLOCATION t(11;18)(q21;q21) AND ITS CORRELATION TO CARCINOGENESIS |
| 02/20/2002 | EP1180159A1 Methods and compositions for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 02/20/2002 | EP1180158A1 Compositions and methods for production of recombinant virus using a carrier vector derived from a nonmammalian virus |
| 02/20/2002 | EP1180157A1 A combined growth factor-deleted and thymidine kinase-deleted vaccinia virus vector |
| 02/20/2002 | EP1180156A1 Methods for induction of tolerance to adenoviral vectors and transgene products |
| 02/20/2002 | EP1180151A2 Protein kinases |
| 02/20/2002 | EP1180150A2 Nucleic acid immunization |
| 02/20/2002 | EP1180143A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 02/20/2002 | EP1180140A1 Variants of traf2 which act as an inhibitor of tnf-alpha signaling pathway |
| 02/20/2002 | EP1180120A2 Variant of the plasmodium merozoite surface protein (msp-1) and vaccine comprising said variant |
| 02/20/2002 | EP1180113A1 Oligonucleotides having a-dna form and b-dna form conformational geometry |
| 02/20/2002 | EP1180040A2 Methods for treating congestive heart failure |
| 02/20/2002 | EP1180039A2 Factor for regulation of neurite growth |
| 02/20/2002 | EP1180016A2 Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases |
| 02/20/2002 | EP1180000A1 Prosthetic grafts |
| 02/20/2002 | EP0964704B1 Compositions for nucleic acid targeting |
| 02/20/2002 | CN1336959A Method for introducing substances into cells and use of said method |
| 02/20/2002 | CN1336957A BASB006 polynucleotide(s) and polypeptides from neisseria meningitis |
| 02/20/2002 | CN1336935A Compositions and methods for WT1 specific immunotherapy |
| 02/20/2002 | CN1336158A Dynamic observation method of tumor and angiogenesis |
| 02/19/2002 | US6348585 Amino acid sequence; treatment and diagnosis of cardiovascular, nervous system, and psychological disorders; antiulcer agents; hypotensive/hypertensive agents |
| 02/19/2002 | US6348583 Nucleobase containing polythioethers synthesized on polyethylene glycol, succinic anhydride and propylamine modified glass; nucleic acid mimetics |
| 02/19/2002 | US6348582 Prokaryotic polynucleotides polypeptides and their uses |
| 02/19/2002 | US6348579 FtsL |
| 02/19/2002 | US6348578 Apt |
| 02/19/2002 | US6348450 Noninvasive genetic immunization, expression products therefrom and uses thereof |
| 02/19/2002 | US6348449 Methods of inducing mucosal immunity |
| 02/19/2002 | US6348353 Artificial mammalian chromosome |
| 02/19/2002 | US6348352 Purging tumor cells from a hematopoietic progenitor cell population by introducing a stable tumor suppressor gene into a heterogeneous cell population and selectively transducing phenotypically hyperproliferative cells |
| 02/19/2002 | US6348340 Compounds |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/19/2002 | US6348327 Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells |
| 02/19/2002 | US6348196 Feline polynucleotide vaccine formula |
| 02/14/2002 | WO2002012565A1 Association of sim2 with cancer |
| 02/14/2002 | WO2002012539A2 Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis |
| 02/14/2002 | WO2002012524A2 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 02/14/2002 | WO2002012523A2 Transduction of chondrocytes using adenoviral vectors |
| 02/14/2002 | WO2002012506A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | WO2002012502A2 Anti-tnf antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012496A1 P53-dependent novel apoptosis-associated protein and method of screening apoptosis controlling agent |
| 02/14/2002 | WO2002012488A1 A novel polypeptide- zinc finger protein 8.8 and the polynucleotide encoding said polypeptide |
| 02/14/2002 | WO2002012470A2 A member of the lysyl oxidase gene family |
| 02/14/2002 | WO2002012469A2 A human adenylate kinase family member and uses therefor |
| 02/14/2002 | WO2002012461A2 Regulation of human membrane-type serine protease |
| 02/14/2002 | WO2002012460A2 Isolation of a human amine oxidase-like protein |
| 02/14/2002 | WO2002012453A1 Method for reducing specific immune reactions |
| 02/14/2002 | WO2002012452A2 Pancreatic progenitor cells |
| 02/14/2002 | WO2002012341A2 Her-2/neu fusion proteins |
| 02/14/2002 | WO2002012325A2 Suppressor gene |
| 02/14/2002 | WO2002012322A1 A new polypeptide-human fk506 binding protein 12.32 and the polynucleotide encoding it |
| 02/14/2002 | WO2002012320A1 A novel peptide---human tnfr/ngfr protein including cytochrome c domain and the polynucleotide coding this novel peptide |
| 02/14/2002 | WO2002012313A1 A novel polypeptide - human protein phosphatase 12.43 and a polynucleotide encoding the same |
| 02/14/2002 | WO2002012310A1 A novel polypeptide - human g-protein subunit 12.65 and a polynucleotide encoding the same |
| 02/14/2002 | WO2002012309A1 A new polypeptide- phytochrome 9.9 and the polynucleotide encoding it |
| 02/14/2002 | WO2002012308A1 A new polypeptide-human rs3 protein 18 and the polynucleotide encoding it |
| 02/14/2002 | WO2002012306A1 A novel polypeptide-the human non-integrin metalloprotease 10.67 and the polynucleotide encoding said polypeptide |
| 02/14/2002 | WO2002012299A1 A novel polypeptide-human protein kinase 27.17 and the polynucleotide encoding said polypeptide |
| 02/14/2002 | WO2002012290A2 Sid polypeptides binding to pathogenic strain of the hepatitis c virus |
| 02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | WO2002012263A1 Nucleic acid binding compounds containing pyrazolo[3,4-d]pyrimidine analogues of purin-2,6-diamine and their uses |
| 02/14/2002 | WO2002011785A2 Manipulation of arterial-venous identity |
| 02/14/2002 | WO2002011769A1 Vascular endothelial growth factor 2 |